Engerix B

Engerix B is a vaccine designed to prevent hepatitis B, a viral infection affecting the liver. It contains hepatitis B surface antigen (rDNA) and alum as an adjuvant. This vaccine is suitable for individuals at risk of hepatitis B infection.

Engerix B is used to protect against hepatitis B, a serious liver infection caused by the hepatitis B virus. It is commonly administered to individuals who are at higher risk of exposure, such as healthcare workers, travelers to regions with high hepatitis B prevalence, and those with certain medical conditions. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus.

Common effects of Engerix B may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue. These effects are usually temporary and resolve on their own. Severe allergic reactions are rare but can occur.

Before receiving Engerix B, inform your healthcare provider about any allergies, especially to yeast or any components of the vaccine. It is important to disclose your medical history, including any immune system disorders or recent illnesses. The vaccine should be administered by a healthcare professional.

Engerix B may interact with certain medications that affect the immune system. It is advisable to discuss all current medications with your healthcare provider before receiving the vaccine. Alcohol and other substances that weaken the immune system may also impact the vaccine's effectiveness.